Sign up to save your podcasts
Or
Share Frequency for dosing of oral iron; Risk of late recurrence after endocrine therapy for breast cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Frequency for dosing of oral iron; Risk of late recurrence after endocrine therapy for breast cancer
In this episode of UpToDate Talk, Dr. Stanley Schrier joins us to discuss an article from Lancet Haematology on a new paradigm for the dosing of oral iron, and Dr. Dan Hayes discusses his meta-analysis from the New England Journal of Medicine on the risk of late recurrence after adjuvant endocrine therapy for breast cancer. Dr. Jennifer Tirnauer hosts.
Figure on hepcidin in UpToDate: https://www.uptodate.com/contents/image?imageKey=HEME%2F105245
View all episodes
By UpToDate
4.3
121121 ratings
In this episode of UpToDate Talk, Dr. Stanley Schrier joins us to discuss an article from Lancet Haematology on a new paradigm for the dosing of oral iron, and Dr. Dan Hayes discusses his meta-analysis from the New England Journal of Medicine on the risk of late recurrence after adjuvant endocrine therapy for breast cancer. Dr. Jennifer Tirnauer hosts.
Figure on hepcidin in UpToDate: https://www.uptodate.com/contents/image?imageKey=HEME%2F105245